2016 VAM: 4301 - Novel Endotypes of Asthma: Lessons from the AADCRC
This session will review clinically important asthma endotypes and the mechanisms that regulate the clinical expression of disease.
AMA PRA Category 1 Credits™: 1.25
CE: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Target Audience
Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals
Learning Objectives
Upon completion of this activity, participants will be able to:
1. Describe Th2 High asthma phenotype and treatment
2. Describe presentation and management of AERD
3. Discuss the role of pollution in asthma pathogenesis, from mechanism to management
Additional Information
Attachment | Size |
---|---|
2016 Annual Meeting Disclosures | 120.13 KB |
Dr. Eric B. Brandt, PhD FAAAAI, Cincinnati Children's Hospital, Cincinnati, OH
Relevant relationships: None
Dr. Tanya M. Laidlaw, MD FAAAAI, Brigham and Women's Hospital, Boston, MA
Relevant relationships: Consultant: Ora, Inc, Array BioPharma, Inc., Array BioPharma, Inc
Dr. Prescott Woodruff, MD MPH, University of California, San Francisco, San Francisco, CA
Relevant relationships: None
Annual Meeting sessions and faculty were reviewed by members of the Practice Improvement Subcommittee. Disclosures are located in the 2016 Annual Meeting Disclosures PDF.
Available Credit
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.